Padmanabh P. Bhatt
Sr. VP of IP; CSO, SUPERNUS PHARMACEUTICALS, INC.
Companies
- SUPERNUS PHARMACEUTICALS, INC.Sr. VP of IP; CSO Apr 30, 2012 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- SUPERNUS PHARMACEUTICALS, INC. SUPN18,637 shares2$741.4K at $39.78Aug 12, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 12, 2026Shares withheld for tax 1,158 shares at $46.57 of SUPERNUS PHARMACEUTICALS, INC.2
- Aug 12, 2026Exercised options 2,500 shares of SUPERNUS PHARMACEUTICALS, INC.2
- Mar 18, 2026Sold 412 shares at $50.48 of SUPERNUS PHARMACEUTICALS, INC.3
- Mar 18, 2026Sold 6,838 shares at $49.55 of SUPERNUS PHARMACEUTICALS, INC.3
- Mar 18, 2026Exercised options 7,250 shares at $39.40 of SUPERNUS PHARMACEUTICALS, INC.3
- Mar 17, 2026Sold 22,290 shares at $50.73 of SUPERNUS PHARMACEUTICALS, INC.3
- Mar 17, 2026Sold 27,710 shares at $49.95 of SUPERNUS PHARMACEUTICALS, INC.3
- Mar 17, 2026Exercised options 15,000 shares at $38.60 of SUPERNUS PHARMACEUTICALS, INC.3
- Mar 17, 2026Exercised options 12,250 shares at $36.75 of SUPERNUS PHARMACEUTICALS, INC.3
- Mar 17, 2026Exercised options 22,750 shares at $39.40 of SUPERNUS PHARMACEUTICALS, INC.3
- Mar 16, 2026Sold 15,886 shares at $50.49 of SUPERNUS PHARMACEUTICALS, INC.3
- Mar 16, 2026Sold 34,114 shares at $50.18 of SUPERNUS PHARMACEUTICALS, INC.3
- Mar 16, 2026Exercised options 5,000 shares at $27.94 of SUPERNUS PHARMACEUTICALS, INC.3
- Mar 16, 2026Exercised options 18,000 shares at $32.20 of SUPERNUS PHARMACEUTICALS, INC.3
- Mar 16, 2026Exercised options 4,250 shares at $29.61 of SUPERNUS PHARMACEUTICALS, INC.3
- Mar 16, 2026Exercised options 22,750 shares at $36.75 of SUPERNUS PHARMACEUTICALS, INC.3
- Feb 25, 2026Shares withheld for tax 650 shares at $50.69 of SUPERNUS PHARMACEUTICALS, INC.4
- Feb 25, 2026Granted 1,250 shares of SUPERNUS PHARMACEUTICALS, INC.4
- Feb 24, 2026Shares withheld for tax 646 shares at $50.86 of SUPERNUS PHARMACEUTICALS, INC.5
- Feb 24, 2026Granted 1,250 shares of SUPERNUS PHARMACEUTICALS, INC.5
- Feb 24, 2026Shares withheld for tax 354 shares at $50.86 of SUPERNUS PHARMACEUTICALS, INC.5
- Feb 24, 2026Granted 750 shares of SUPERNUS PHARMACEUTICALS, INC.5
- Feb 24, 2026Shares withheld for tax 581 shares at $51.35 of SUPERNUS PHARMACEUTICALS, INC.5
- Feb 24, 2026Granted 1,125 shares of SUPERNUS PHARMACEUTICALS, INC.5
- Dec 18, 2025Sold 710 shares at $44.44 of SUPERNUS PHARMACEUTICALS, INC.6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Mar 18, 2026
- 4SEC EDGARForm 4 filed Feb 26, 2026
- 5SEC EDGARForm 4 filed Feb 25, 2026
- 6SEC EDGARForm 4 filed Dec 19, 2025